Help stop tooth decay...and prevent RA?

Journal of Rheumatology

Volumn 37, Issue 6, 2010, Pages 1083-1085

  Mikuls, Ted R ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA DR ANTIGEN; IMMUNOGLOBULIN G ANTIBODY; LIPOPOLYSACCHARIDE; MATRIX METALLOPROTEINASE; RHEUMATOID FACTOR; TUMOR NECROSIS FACTOR;

ALVEOLAR BONE LOSS; DENTAL CARIES; EDITORIAL; GINGIVA BLEEDING; HUMAN; MOUTH HYGIENE; OSTEOARTHRITIS; PERIODONTAL DISEASE; PERIODONTITIS; PORPHYROMONAS GINGIVALIS; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SMOKING; TOOTH PLAQUE;

ARTHRITIS, RHEUMATOID; DENTAL CARIES; HUMANS; PORPHYROMONAS GINGIVALIS;

EID: 77953192461     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: 10.3899/jrheum.100173     Document Type: Editorial

References (13)

1. Snyderman R, McCarty GA. Analogous mechanism of tissue destruction in rheumatoid arthritis and periodontal disease. In: Genco R, Mergenhagen S, editors. Host-parasite interactions in periodontal diseases. Washington, DC: American Society for Microbiology; 1982:354-362
2. Assuma R, Oates T, Cochran D, Amar S, Graves DT. IL-1 and TNF antagonists inhibit the inflammatory response and bone loss in experimental periodontitis. J Immunol 1998;160:403-409 (Pubitemid 28116755)
3. Delima AJ, Oates T, Assuma R, Schwartz Z, Cochran D, Amar S, et al. Soluble antagonists to interleukin-1 (IL-1) and tumor necrosis factor (TNF) inhibits loss of tissue attachment in experimental periodontitis. J Clin Periodontol 2001;28:233-240 (Pubitemid 33755189)
4. Graves DT, Delima AJ, Assuma R, Amar S, Oates T, Cochran D. Interleukin-1 and tumor necrosis factor antagonists inhibit the progression of inflammatory cell infiltration toward alveolar bone in experimental periodontitis. J Periodontol 1998;69:1419-1425
5. Kasser UR, Gleissner C, Dehne F, Michel A, Willershausen-Zonnchen B, Bolten WW. Risk for periodontal disease in patients with longstanding rheumatoid arthritis. Arthritis Rheum 1997;40:2248-2251
6. Mercado FB, Marshall RI, Klestov AC, Bartold PM. Relationship between rheumatoid arthritis and periodontitis. J Periodontol 2001;72:779-787
7. Dissick A, Redman RS, Jones M, Rangan BV, Reimold A, Griffiths GR, et al. Association of periodontitis with rheumatoid arthritis: a pilot study. J Periodontol 2010;81:223-230
8. Mikuls TR, Payne JB, Reinhardt RA, Thiele GM, Maziarz E, Cannella AC, et al. Antibody responses to Porphyromonas gingivalis (P. gingivalis) in subjects with rheumatoid arthritis and periodontitis. Int Immunopharmacol 2009;9:38-42.
9. Hitchon CA, Chandad F, Ferucci ED, Willemze A, Ioan-Facsinay A, van der Woude D, et al. Antibodies to Porphyromonas gingivalis are associated with anti-citrullinated protein antibodies in RA patients and their relatives. J Rheumatol 2010;37:1105-1113
10. Rantapaa-Dahlqvist S, de Jong BA, Berglin E, Hallmans G, Wadell G, Stenlund H, et al. Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. Arthritis Rheum 2003;48:2741-2749
11. Snir O, Widhe M, von Spee C, Lindberg J, Padyukov L, Lundberg K, et al. Multiple antibody reactivities to citrullinated antigens in sera from rheumatoid arthritis patients - association with HLA-DRB1 alleles. Ann Rheum Dis 2008;68:736-743
12. Imamura T. The role of gingipains in the pathogenesis of periodontal disease. J Periodontol 2003;74:111-118
13. Lundberg K, Kinloch A, Fisher BA, Wegner N, Wait R, Charles P, et al. Antibodies to citrullinated alpha-enolase peptide 1 are specific for rheumatoid arthritis and cross-react with bacterial enolase. Arthritis Rheum 2008;58:3009-3019